학술논문
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome
Document Type
Article
Author
Source
In: Blood . (Blood, 2 March 2023, 141(9):971-983)
Subject
Language
English
ISSN
15280020
00064971
00064971